Welcome to our dedicated page for Dogecoin Cash news (Ticker: CBDS), a resource for investors and traders seeking the latest updates and insights on Dogecoin Cash stock.
Cannabis Sativa Inc (CBDS) combines herbal wellness innovation with blockchain technology, operating at the intersection of natural products and digital asset strategies. This news hub provides investors and industry observers with verified updates on the company's dual focus areas.
Access timely announcements covering new product launches in herbal skincare, cannabis telemedicine developments through Presto Doctor, and blockchain integration initiatives. The repository includes earnings reports, regulatory filings, partnership announcements, and technology updates from CBDS subsidiaries like Wild Earth Naturals and iBuddTender.
Bookmark this page for structured access to CBDS's latest operational milestones, including patent filings, digital asset acquisitions, and market expansion efforts. All content is sourced from official company communications to ensure compliance with financial disclosure standards.
Cannabis Sativa (OTCQB:CBDS) announced that PrestoDoctor is now offering online medical cannabis card services in Texas. The COO, Rob Tankson, emphasized the service's accessibility for patients, while CEO David Tobias highlighted the potential for increased patient appointments and revenue. Established in 2015, PrestoDoctor has served over 100,000 patients across eight states and is praised for its patient satisfaction, holding more than 18,000 5-star reviews. The company is committed to providing compassionate care and education through telemedicine.
Cannabis Sativa Inc. (CBDS) announced a Letter of Intent to merge with MJ Harvest, Inc. (MJHI). This merger will transition CBDS's operations from telehealth to a vertically integrated cannabis business, consolidating operations in seven states. MJHI, which operates extraction and manufacturing facilities, holds significant cannabis licenses and brand partnerships. The merger terms include MJHI shareholders receiving 2.7 shares of CBDS for each MJHI share. Following the merger, MJHI will cease to exist, with CBDS becoming the surviving entity.
Cannabis Sativa, Inc. (CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the 8th Annual Pennsylvania Cannabis Festival on April 23-24, 2022. This event will take place at Renninger's Farmers Market in Kutztown, PA, featuring over 250 vendors. COO Rob Tankson emphasized the ease of obtaining medical cannabis recommendations during the festival, leveraging proprietary technology to streamline the process. PrestoDoctor has conducted over 100 similar events, maintaining high customer satisfaction ratings. CBDS focuses on telehealth, cannabis-related IP, and ancillary services.
Cannabis Sativa (OTCQB:CBDS) announced that CBGA, a compound in its patented Equadorian Sativa strain, effectively blocks the entry of COVID-19 into human cells, as reported in the Journal of Natural Products. The study indicates that CBGA must be taken orally for potential prevention and treatment of SARS-CoV-2. CEO David Tobias emphasized the importance of this finding and the ongoing research for effective product delivery protocols.
Cannabis Sativa (OTCQB:CBDS) announced that its Brand Ambassador, Randy Lanier, is featured in Netflix's "Need for Weed", part of the "Bad Sport" docuseries. The episode highlights Lanier's dual career as a race car driver and cannabis importer, detailing his achievements, including the 1984 IMSA Championship and Rookie of the Year at the 1986 Indianapolis 500. Lanier now supports cannabis prisoners via Freedom Grow. CEO David Tobias emphasizes the public’s growing acceptance of cannabis legalization, stating that the docuseries tells a critical story in cannabis history.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will be a Diamond Sponsor at the Pennsylvania Cannabis Fall Marketplace on October 2 & 3. The event will be held at Renninger's Farmers Market in Kutztown, featuring free admission and over 50 vendors. PrestoDoctor will provide on-site medical evaluations, utilizing their proprietary technology for efficient sign-ups. As a top-rated online cannabis recommendation service, PrestoDoctor has earned over 17,000 five-star reviews and has helped thousands of patients obtain medical cannabis cards across several states.
Cannabis Sativa (OTCQB:CBDS) has launched Cannabis Sativa Magazine, a new digital news platform focusing on cannabis and hemp industry insights. The magazine aims to cover a variety of topics including investor news, politics, lifestyle, and health. CEO David Tobias emphasized that this new domain enhances their intellectual property portfolio. The company continues to explore direct cannabis involvement through innovations in a patented cannabis strain and aims for vertical integration in the industry to improve control over supply chains and product quality.
Cannabis Sativa, Inc. (OTCQB:CBDS) has signed a Term Sheet to acquire Stratum Brands, a cannabis product manufacturer based in Los Angeles, with a 2020 revenue of $2.8 million. Stratum offers various product lines, including Cobra Extracts and LA Kingpins vapes, distributed across over 50 California dispensaries. The acquisition will involve issuing stock valued at $1.715 million for 49% ownership, with an option for further investment post-audit. This strategic move aims to enhance Cannabis Sativa's manufacturing and distribution capabilities.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported Q1 2021 revenues of $557,323, with its subsidiary PrestoDoctor contributing $482,350 and achieving a margin of 62%. This represents a 13% growth compared to Q1 2020. Management anticipates further growth driven by PrestoDoctor’s expansion into newly legalized states for medical marijuana and effective advertising campaigns in Oklahoma and Iowa. The company aims to enhance its presence in the cannabis market through vertical integration, including cultivating its unique cannabis strain and acquiring dispensaries.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported a 75% increase in revenue for the fiscal year ending December 31, 2020, reaching $2,035,383, compared to $1,159,737 in 2019. This growth is attributed to its 51% owned subsidiary PrestoCorp, which benefited from the surge in telemedicine demand due to COVID-19. However, its other subsidiary, GK Manufacturing and Packaging, reported lower revenues of $94,552 and a cost of revenues of $152,837. The company has invested $750,000 in GKMP, which is facing delays in operations.